Source: PR Newswire

Press Release: Corium : Journal Frontiers in Psychiatry Publishes Analysis of Open Label Safety Study Showing Improvements in Sleep Habits for Children With ADHD After Treatment With AZSTARYS (serdexmethylphenidate and dexmethylphenidate)

Sleep domain score improvements were statistically significant and observed throughout the twelve-month study BOSTON, June 26, 2023 /PRNewswire/ -- Corium, LLC, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS)...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Perry J. Sternberg's photo - President & CEO of Corium

President & CEO

Perry J. Sternberg

CEO Approval Rating

90/100

Read more